Whole Blood Mycobacterial Growth Assays for Assessing Human Tuberculosis Susceptibility: A Systematic Review and Meta-Analysis

por Bok, Jeroen, Hofland, Regina W., Evans, Carlton A.
Publicado 2021

Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators

por Aalbers, Bente L., Bronsveld, Inez, Hofland, Regina W., Heijerman, Harry G. M.
Publicado 2021

Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q

por Niewold, Paula, Dijkstra, Douwe J., Cai, Yi, Goletti, Delia, Palmieri, Fabrizio, van Meijgaarden, Krista E., Verreck, Frank A. W., Akkerman, Onno W., Hofland, Regina W., Delemarre, Eveline M., Nierkens, Stefan, Verheul, Marije K., Pollard, Andrew J., van Dissel, Jaap T., Ottenhoff, Tom H. M., Trouw, Leendert A., Joosten, Simone A.
Publicado 2023

Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis

por Delemarre, Eveline M., van Hoorn, Laura, Bossink, Aik W. J., Drylewicz, Julia, Joosten, Simone A., Ottenhoff, Tom H. M., Akkerman, Onno W., Goletti, Delia, Petruccioli, Elisa, Navarra, Assunta, van den Broek, Brigitte T. A., Paardekooper, Sanne P. A., van Haeften, Ineke, Koenderman, Leo, Lammers, Jan-Willem J., Thijsen, Steven F. T., Hofland, Regina W., Nierkens, Stefan
Publicado 2021